Validating RWD against clinical trial data
In a recent study with a top 10 global pharmaceutical company, researchers explored how real-world data (RWD) compares to the gold standard of clinical trial data — specifically, whether RWD can reliably replicate clinical trial control arm estimates in early-stage melanoma.
What’s inside:
- Study results highlighted that RWD can produce outcomes consistent with clinical control arm estimates
- Demonstration of RWD’s reliability in early-stage melanoma
- Increased confidence in the reliability of early-stage real-world outcomes for understanding treatment effectiveness
Download the case study to see how RWD can complement clinical trial data in oncology research.